Nn2211-3965
Research payments
$147,362
Through program year 2025, $147,362 in research payments was reported against Nn2211-3965, across 141 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $36,031 | 23 |
| 2024 | Research | $4,558 | 7 |
| 2023 | Research | $36,461 | 32 |
| 2021 | Research | $28,564 | 19 |
| 2020 | Research | $6,828 | 5 |
| 2019 | Research | $34,920 | 55 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Thomas Tucker Versailles, KY Named on 24 payments
- Herbert Chen Birmingham, AL Named on 15 payments
- Thomas Tucker Tulsa, OK Named on 13 payments
- Charles Lynch Iowa City, IA Named on 4 payments
- Rachel Sobel Franklin, TN Named on 1 payment
- Robert Smallridge Jacksonville, FL Named on 1 payment
- Negah Rassouli Atlanta, GA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.